Etiology


  • Infection of the endocardium, most commonly affecting heart valves.
  • Pathogenesis: Endothelial damage → sterile platelet-fibrin thrombus (nonbacterial thrombotic endocarditis) → transient bacteremia seeds the thrombus → vegetation formation.

Pathogens

  • ** S. aureus **: Most common cause overall, especially in IV drug users (IVDU), healthcare-associated infections, and acute, aggressive presentations.
  • ** Viridans group streptococci ** (S. sanguinis): Associated with poor dentition and recent dental procedures; typically causes subacute IE on previously damaged valves.
  • ** S. bovis (S. gallolyticus) **: Strongly associated with colon cancer; a workup for colonic malignancy is required if isolated.
  • Enterococci (E. faecalis): Common after GU/GI procedures and in nosocomial settings.
  • Coagulase-negative staphylococci (S. epidermidis): Associated with prosthetic valves, especially within the first year of placement.
  • HACEK organisms: Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella. Part of normal oral flora, associated with culture-negative endocarditis.
  • Fungi (Candida, Aspergillus): Seen in immunocompromised patients, IVDU, and after prolonged antibiotic therapy.

Risk factors for infective endocarditis

  • Cardiac conditions
  • Noncardiac risk factors
    • Poor dental status
    • Dental procedures
    • Nonsterile venous injections (e.g., in IV drug use)
    • Intravascular devices
    • Surgery

Pathophysiology


  • Pathogenesis
    1. Damaged valvular endothelium → exposure of the subendothelial layer → adherence of platelets and fibrin → sterile vegetation (microthrombus)
    2. Localized infection or contamination → bacteremia → bacterial colonization of vegetation → formation of fibrin clots encasing the vegetation → valve destruction with loss of function (valve regurgitation)
  • Clinical consequences
    • Bacterial vegetation → bacterial thromboemboli → vessel occlusion → infarctions
    • Emboli can lead to metastatic infections of other organs.

Classifications


Coagulase-negative staphylococci (CoNS): Staphylococcus epidermidis, Staphylococcus saprophyticus

Clinical features


Cardiac manifestations

  • Development of a new heart murmur or change in a preexisting murmur
    • Tricuspid valve regurgitation
      • Holosystolic murmur that is loudest at the left sternal border
      • Seen in persons who inject drugs, immunocompromised individuals, patients with congenital heart disease, and patients with instrumentation in the right heart (e.g., central venous catheters)
    • Aortic valve regurgitation: early diastolic murmur that is loudest at the left 3rd and 4thintercostal spaces and along the left sternal border
    • Mitral valve regurgitation: holosystolic murmur that is loudest at the heart’s apex and radiates to the left axilla

Extracardiac manifestations of IE

  • Pulmonary manifestations: caused by septic emboli resulting from tricuspid valve involvement
    • Signs of pulmonary embolism (e.g., dyspnea)
    • Signs of pulmonary infection, e.g., multifocal pneumonia, lung abscess, and/or empyema.

Diagnostics


vs rheumatic fever